170 related articles for article (PubMed ID: 33858547)
1. Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study.
Pascale R; Bussini L; Gaibani P; Bovo F; Fornaro G; Lombardo D; Ambretti S; Pensalfine G; Appolloni L; Bartoletti M; Tedeschi S; Tumietto F; Lewis R; Viale P; Giannella M
Infect Control Hosp Epidemiol; 2022 Apr; 43(4):461-466. PubMed ID: 33858547
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
3. Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.
Enfield KB; Huq NN; Gosseling MF; Low DJ; Hazen KC; Toney DM; Slitt G; Zapata HJ; Cox HL; Lewis JD; Kundzins JR; Mathers AJ; Sifri CD
Infect Control Hosp Epidemiol; 2014 Jul; 35(7):810-7. PubMed ID: 24915208
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of digestive tract colonization of carbapenem-resistant Acinetobacter baumannii in hospitals in Saudi Arabia.
Aljindan R; Bukharie H; Alomar A; Abdalhamid B
J Med Microbiol; 2015 Apr; 64(Pt 4):400-406. PubMed ID: 25657302
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the mechanism of drug resistance of VIM-2-type metallo-β-lactamase-producing Acineto- bacter baumannii isolated from burn patients and its homology].
Xili Y; Yue L; Jianhua Z; Fei G; Dinghong M; Nianyun W; Guohui L; Guanghua G
Zhonghua Shao Shang Za Zhi; 2015 Jun; 31(3):205-10. PubMed ID: 26564568
[TBL] [Abstract][Full Text] [Related]
7. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Vrizas D; Diomidous M; Pournaras S; Markou F
Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic characterization of carbapenem-resistant
Abouelfetouh A; Torky AS; Aboulmagd E
Antimicrob Resist Infect Control; 2019; 8():185. PubMed ID: 31832185
[TBL] [Abstract][Full Text] [Related]
9. [Program for the prevention of Carbapenemase-Producing Enterobacteria in critical units in Argentina during the COVID-19 pandemic].
Staneloni MI; Alonso L; Ilari S; Herrera MP; López C; Colque Á
Medicina (B Aires); 2022; 82(5):722-731. PubMed ID: 36220029
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India.
Mittal G; Gaind R; Kumar D; Kaushik G; Gupta KB; Verma PK; Deb M
BMC Microbiol; 2016 Jul; 16(1):138. PubMed ID: 27392139
[TBL] [Abstract][Full Text] [Related]
11. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
[TBL] [Abstract][Full Text] [Related]
12. Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients.
Martins N; Martins IS; de Freitas WV; de Matos JA; Girão VB; Coelho-Souza T; Maralhães AC; Cacci LC; de Figueiredo MP; Dias RC; Costa-Lourenço AP; Ferreira AL; Dalla-Costa L; Nouér SA; Santoro-Lopes G; Riley LW; Moreira BM
Microb Drug Resist; 2013 Jun; 19(3):216-23. PubMed ID: 23336529
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
[TBL] [Abstract][Full Text] [Related]
14. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
[TBL] [Abstract][Full Text] [Related]
15. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-Resistant and Carbapenemase-Producing
Tekele SG; Teklu DS; Legese MH; Weldehana DG; Belete MA; Tullu KD; Birru SK
Biomed Res Int; 2021; 2021():9999638. PubMed ID: 34195291
[TBL] [Abstract][Full Text] [Related]
17. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant
Ranjbar R; Farahani A
Antimicrob Resist Infect Control; 2019; 8():172. PubMed ID: 31719975
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
[TBL] [Abstract][Full Text] [Related]
19. Adaptations of carbapenem resistant
Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
[No Abstract] [Full Text] [Related]
20. [Drug resistance of
Xu CF; Xu W
Zhonghua Er Ke Za Zhi; 2021 Aug; 59(8):651-657. PubMed ID: 34333917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
